19596 Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices 

Dated: April 17, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–9795 Filed 4–28–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated December 22, 2008, 

and published in the Federal Register 

on December 31, 2008 (73 FR 80431), 

Johnson Matthey Inc., Pharmaceutical 

Materials, 2003 Nolte Drive, West 

Deptford, New Jersey 08066–1742, has 

made application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Thebaine (9333) ........................... II 

Noroxymorphone (9668) ............... II 

The company plans to import 

analytical reference standards for 

distribution to its customers for research 

purposes. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Johnson Matthey Inc. to import the basic 

classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Johnson 

Matthey Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: April 17, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–9791 Filed 4–28–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated January 9, 2009, and 

published in the Federal Register on 

January 21, 2009 (74 FR 3642), Noramco 

Inc., 1440 Olympic Drive, Athens, 

Georgia 30601, made application by 

letter to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Thebaine (9333), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to import 

analytical reference standards for 

distribution to its customers for research 

purposes. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Noramco Inc. to import the basic class 

of controlled substance is consistent 

with the public interest, and with 

United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated 

Noramco Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: April 17, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–9788 Filed 4–28–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated February 5, 2009, and 

published in the Federal Register on 

February 11, 2009 (74 FR 6920), Roche 

Diagnostics Operations Inc., Attn: 

Regulatory Compliance, 9115 Hague 

Road, Indianapolis, Indiana 46250, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (7370) ..... I 

Alphamethadol (9605) .................. I 

Cocaine (9041) ............................. II 

Ecgonine (9180) ........................... II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to import the 

listed controlled substances for the 

manufacture of diagnostic products for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Roche Diagnostics Operations Inc. to 

import the basic classes of controlled 

substances is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971, at this time. DEA has 

investigated Roche Diagnostics 

Operations Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: April 17, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–9784 Filed 4–28–09; 8:45 am] 

BILLING CODE 4410–09–P 


pwalker on PROD1PC71 with NOTICES